In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BD’s R&D Pipeline Includes Micro-Needle Drug Delivery; Q4 Sales Up 8%

This article was originally published in The Gray Sheet

Executive Summary

BD is preparing for functionality testing of its development-stage Micro Infuser wearable drug-delivery system, incorporating micro-needles to deliver drugs just below the skin's surface to minimize pain

You may also be interested in...



BD Ups R&D Spending, Focusing On Drug Delivery And Diabetes Research

Becton Dickinson is investing in research on the use of micro-needles and needleless technologies in advanced drug delivery systems

BD Ups R&D Spending, Focusing On Drug Delivery And Diabetes Research

Becton Dickinson is investing in research on the use of micro-needles and needleless technologies in advanced drug delivery systems

BD Logic

Blood glucose meter gains expanded 510(k) clearance for alternate-site testing using blood from the palm and forearm. The expanded clearance also includes BD's Paradigm Link blood glucose meter, co-developed with Medtronic, and "makes palm testing the equivalent to fingertip testing," according to BD...

Related Content

UsernamePublicRestriction

Register

MT021197

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel